Neurologic complications after liver transplantation

作者: Saša A Živković

DOI: 10.4254/WJH.V5.I8.409

关键词:

摘要: Neurologic complications are relatively common after solid organ transplantation and affect 15%-30% of liver transplant recipients. Etiology is often related to immunosuppressant neurotoxicity opportunistic infections. Most include seizures encephalopathy, occurrence central pontine myelinolysis specific for Delayed allograft function may precipitate hepatic encephalopathy calcineurin inhibitors typically manifests with tremor, headaches encephalopathy. Reduction neurotoxic immunosuppressants or conversion an alternative medication usually result in clinical improvement. Standard preventive diagnostic protocols have helped reduce the prevalence nervous system (CNS) infections, but viral fungal CNS infections still 1% recipients, morbidity mortality affected patients remain fairly high. Critical illness myopathy also up 7% Liver insufficiency associated various neurologic disorders which improve resolve successful transplantation. Accurate diagnosis timely intervention essential outcomes, while advances management extended post-transplant survival increasingly shifting focus chronic encountered a community hospital outpatient setting.

参考文章(73)
Xavier Verhelst, Geert Vanhooren, Ludo Vanopdenbosch, Jan Casselman, Wim Laleman, Jacques Pirenne, Frederik Nevens, Hans Orlent, Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature. Transplant International. ,vol. 24, ,(2011) , 10.1111/J.1432-2277.2010.01190.X
G. Wu, R.A. Vilchez, B. Eidelman, J. Fung, R. Kormos, S. Kusne, Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients Transplant Infectious Disease. ,vol. 4, pp. 183- 188 ,(2002) , 10.1034/J.1399-3062.2002.T01-1-02005.X
Eelco F. M. Wijdicks, Impaired consciousness after liver transplantation Liver Transplantation. ,vol. 1, pp. 329- 334 ,(1995) , 10.1002/LT.500010511
E Wijdicks, Neurotoxicity of immunosuppressive drugs Liver Transplantation. ,vol. 7, pp. 937- 942 ,(2001) , 10.1053/JLTS.2001.27475
Eelco F. M. Wijdicks, Paola R. Blue, Jeffery L. Steers, Russell H. Wiesner, Central pontine myelinolysis with stupor alone after orthotopic liver transplantation Liver Transplantation. ,vol. 2, pp. 14- 16 ,(1996) , 10.1002/LT.500020104
Andrea Stracciari, Antonella Tempestini, Annamaria Borghi, Maria Guarino, Effect of Liver Transplantation on Neurological Manifestations in Wilson Disease JAMA Neurology. ,vol. 57, pp. 384- 386 ,(2000) , 10.1001/ARCHNEUR.57.3.384
Jeffrey J. Gaynor, Jang I. Moon, Tomoaki Kato, Seigo Nishida, Gennaro Selvaggi, David M. Levi, Eddie R. Island, Nikolaos Pyrsopoulos, Debbie Weppler, Susan Ganz, Phillip Ruiz, Andreas G. Tzakis, A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation. ,vol. 84, pp. 155- 165 ,(2007) , 10.1097/01.TP.0000269090.90068.0F
N. M. Clark, , Nocardia in Solid Organ Transplant Recipients American Journal of Transplantation. ,vol. 9, ,(2009) , 10.1111/J.1600-6143.2009.02896.X
Camille N. Kotton, Travel and transplantation Current Opinion in Organ Transplantation. ,vol. Publish Ahead of Print, pp. 594- 600 ,(2012) , 10.1097/MOT.0B013E328359266B